REPORT ON TWENTY PATIENTS WITH MALIGNANT DISEASE TREATED WITH CYTOTOXIC AGENTS.
D002294:Carcinoma, Squamous Cell; D002813:Chondrosarcoma; D003520:Cyclophosphamide; D003603:Cytotoxins; D004938:Esophageal Neoplasms; D005260:Female; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008297:Male; D009182:Mycosis Fungoides; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds; D010051:Ovarian Neoplasms; D010412:Penile Neoplasms; D012509:Sarcoma; D012514:Sarcoma, Kaposi; D013274:Stomach Neoplasms; D013727:Terminal Care; D014116:Toxicology; D002583:Uterine Cervical Neoplasms
D003603:Cytotoxins; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide
CARCINOMA, EPIDERMOID; CERVIX NEOPLASMS; CHONDROSARCOMA; CYCLOPHOSPHAMIDE; ESOPHAGEAL NEOPLASMS; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA; MYCOSIS FUNGOIDES; NITROGEN MUSTARD COMPOUNDS; OVARIAN NEOPLASMS; PENILE NEOPLASMS; SARCOMA, KAPOSI'S; SARCOMA, RETICULUM CELL; STOMACH NEOPLASMS; TERMINAL CARE; TOXICOLOGIC REPORT